SCHEMBL16143465

SCHEMBL16143465

CC(C)Cc1ccc(C(=Cc2ccc(C(=O)O)cc2)C(=O)OCc2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ NR4A1 P22736 1/20 0.41
▸ NR4A2 P43354 1/20 0.41
▸ NR4A3 Q92570 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ CTDSP1 Q9GZU7 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ APOBEC3A P31941 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ NR1H4 Q96RI1 1/20 0.40
▸ MIF P14174 1/20 0.40
▸ RXRA P19793 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ RXRB P28702 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ RXRG P48443 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28189813 0.94 KMT2A (0.43) LMNAKMT2AMEN1TDP1NR1H4
SCHEMBL2658114 0.90 ALDH1A1 (0.44) KMT2APKMMIFMAPTALDH1A1
SCHEMBL11999249 0.90 ALDH1A1 (0.44) KMT2APKMMIFMAPTALDH1A1
SCHEMBL2658111 0.90 ALDH1A1 (0.44) KMT2APKMMIFMAPTALDH1A1
SCHEMBL5196952 0.79 AKR1C1 (0.56) LMNAHTTKMT2AMEN1TDP1
SCHEMBL9371236 0.74 ALDH1A1 (0.50) LMNATDP1RXRARXRBALDH1A1
SCHEMBL9371234 0.74 ALDH1A1 (0.50) LMNATDP1RXRARXRBALDH1A1
SCHEMBL8114187 0.74 NPC1 (0.51) LMNAKMT2AMEN1ALDH1A1
SCHEMBL8114190 0.74 NPC1 (0.51) LMNAKMT2AMEN1ALDH1A1
SCHEMBL452233 0.73 PTGS1 (0.60) LMNAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2786985-B1 Antagonists of the glucagon receptor METABASIS THERAPEUTICS INC (US) 2018-11-28 — — EP disclosed
CN-101610995-B Glucagon receptor antagonists 症变治疗公司 2017-08-08 — — CN disclosed
EP-2786985-A2 Antagonists of the glucagon receptor Metabasis Therapeutics, Inc. (US) 2014-10-08 — — EP disclosed
Send feedback